#regenxbio
Latest news and interesting information about regenxbio.
Goldman Sachs cuts Regenxbio target to $10
Goldman Sachs cuts Regenxbio (NASDAQ:RGNX) price target to $10 from $12 on RGX-202 regulatory uncertainty. Stock down 41% to $6.25.
...
→
EN ▾
Barclays: UK energy prices mirror 2011 shockNeedham cuts Globant target to $50 on lower multiplesPMGC Holdings Q1 2026 results, acquisitionsBTIG Reiterates Neutral on Insight Molecular Amid FDA ReviewDoctor error leaves producer permanently disabledIs OTS an Alternative to EU?Gardabani crash death toll rises to 8Ilham Aliyev at TDT Summit in TurkistanHONOR 600 Series launched in AzerbaijanBTIG Reiterates Boot Barn Buy RatingBarclays: UK energy prices mirror 2011 shockNeedham cuts Globant target to $50 on lower multiplesPMGC Holdings Q1 2026 results, acquisitionsBTIG Reiterates Neutral on Insight Molecular Amid FDA ReviewDoctor error leaves producer permanently disabledIs OTS an Alternative to EU?Gardabani crash death toll rises to 8Ilham Aliyev at TDT Summit in TurkistanHONOR 600 Series launched in AzerbaijanBTIG Reiterates Boot Barn Buy Rating